Prognostic implications of circulating Epstein–Barr virus DNA for extranodal natural killer/T-cell lymphoma, nasal type: a meta-analysis

References

• TseEKwongYLHow I treat NK/T-cell lymphomasBlood2013121254997500523652805
   PubMed Web of Science ®Google Scholar
• ZhangTFuQGaoDGeLSunLZhaiQEBV associated lymphomas in 2008 WHO classificationPathol Res Pract20142102697324355441
   PubMed Web of Science ®Google Scholar
• ChanJKCQuintanilla-MartinezLFerryJAPehSCExtranodal NK/T-cell lymphoma, nasal typeSwerdlowSHCampoEHarrisNLWHO Classification of Tumours of Haematopoietic and Lymphoid TissuesLyon, FranceIARC2008285288
   Google Scholar
• ZhouXLuKGengLLiXJiangYWangXUtility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysisMedicine (Baltimore)20149328e25825526450
   PubMed Web of Science ®Google Scholar
• JiangLLiSJJiangYMThe significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysisLeuk Lymphoma20145551038104823885795
   PubMed Web of Science ®Google Scholar
• KimSJKimKKimBSPhase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma studyJ Clin Oncol200927356027603219884539
   PubMed Web of Science ®Google Scholar
• YamaguchiMTobinaiKOguchiMPhase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211J Clin Oncol200927335594560019805668
   PubMed Web of Science ®Google Scholar
• LinNSongYZhengWA prospective phase II study of L-asparaginase-CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal typeJ Hematol Oncol201364423816178
   PubMed Web of Science ®Google Scholar
• JiangMZhangHJiangYPhase 2 trial of “sandwich” L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphomaCancer2012118133294330122139825
   PubMed Web of Science ®Google Scholar
• CheungMMChanJKLauWHNganRKFooWWEarly stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modalityInt J Radiat Oncol Biol Phys200254118219012182990
   PubMed Web of Science ®Google Scholar
• LiYXFangHLiuQFClinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ringBlood200811283057306418676879
   PubMed Web of Science ®Google Scholar
• LeeJSuhCParkYHExtranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter studyJ Clin Oncol200624461261816380410
   PubMed Web of Science ®Google Scholar
• KimTMLeeSYJeonYKLymphoma Subcommittee of the Korean Cancer Study GroupClinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study GroupAnn Oncol20081981477148418385201
   PubMed Web of Science ®Google Scholar
• LeiKIChanLYChanWYJohnsonPJLoYMQuantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignanciesBr J Haematol2000111123924611091207
   PubMed Web of Science ®Google Scholar
• LeungSFZeeBMaBBPlasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinomaJ Clin Oncol200624345414541817135642
   PubMed Web of Science ®Google Scholar
• WilliamsHCrawfordDHEpstein-Barr virus: the impact of scientific advances on clinical practiceBlood2006107386286916234359
   PubMed Web of Science ®Google Scholar
• ChaiSJPuaKCSalehAMalaysian NPC Study GroupClinical significance of plasma Epstein-Barr virus DNA loads in a large cohort of Malaysian patients with nasopharyngeal carcinomaJ Clin Virol2012551343922739102
   PubMed Web of Science ®Google Scholar
• ZhangYXKangSYChenGABO blood group, Epstein-Barr virus infection and prognosis of patients with non-metastatic nasopharyngeal carcinomaAsian Pac J Cancer Prev201415177459746525227859
   PubMedGoogle Scholar
• ChenMYinLWuJImpact of plasma Epstein-Barr virus-DNA and tumor volume on prognosis of locally advanced nasopharyngeal carcinomaBiomed Res Int2015201561794925802858
   PubMed Web of Science ®Google Scholar
• TierneyJFStewartLAGhersiDBurdettSSydesMRPractical methods for incorporating summary time-to-event data into meta-analysisTrials200781617555582
   PubMed Web of Science ®Google Scholar
• SchmidtFLOhISHayesTLFixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in resultsBr J Math Stat Psychol200962Pt 19712818001516
   PubMed Web of Science ®Google Scholar
• WellsGASheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) forassessing the quality if nonrandomized studies inmeta-analyses Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed August 13, 2014
   Google Scholar
• LeiKIChanLYChanWYJohnsonPJLoYMDiagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphomaClin Cancer Res200281293411801537
   PubMed Web of Science ®Google Scholar
• IshiiHOginoTBergerCClinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphomaJ Med Virol20077955627217385697
   PubMed Web of Science ®Google Scholar
• SuzukiRYamaguchiMIzutsuKNK-cell Tumor Study GroupProspective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeBlood2011118236018602221984805
   PubMed Web of Science ®Google Scholar
• WangZYLiuQFWangHClinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyBlood2012120102003201022826562
   PubMed Web of Science ®Google Scholar
• ItoYKimuraHMaedaYPretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extra-nodal NK/T-cell lymphoma, nasal typeClin Cancer Res201218154183419022675173
   PubMed Web of Science ®Google Scholar
• KwongYLPangAWLeungAYChimCSTseEQuantification of circulating Epstein-Barr virus DNA in NK/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significanceLeukemia201428486587023842425
   PubMed Web of Science ®Google Scholar
• KimSJParkSKangESInduction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patientsAnn Hematol2015941717825082384
   PubMed Web of Science ®Google Scholar
• WangLWangHWangJHPost-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginaseOncotarget2015630303173032626210287
   PubMed Web of Science ®Google Scholar
• KimSJChoiJYHyunSHAsia Lymphoma Study GroupRisk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysisLancet Haematol201522e66e7426687611
   PubMed Web of Science ®Google Scholar
• LiangRWangZBaiQXNatural killer/T cell lymphoma, nasal type: a retrospective clinical analysis in North-Western ChinaOncol Res Treat2016391–2455226891121
   PubMed Web of Science ®Google Scholar
• LimSHHyunSHKimHSPrognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTLBone Marrow Transplant201651680781226855154
   PubMed Web of Science ®Google Scholar
• EnnishiDMaedaYFujiiNAllogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal typeLeuk Lymphoma20115271255126121599584
   PubMed Web of Science ®Google Scholar
• SuzukiRSuzumiyaJYamaguchiMNK-cell Tumor Study GroupPrognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal typeAnn Oncol20102151032104019850638
   PubMed Web of Science ®Google Scholar
• YongWZhengWZhangYL-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphomaInt J Hematol200378216316712953813
   PubMed Web of Science ®Google Scholar
• YouJYChiKHYangMHRadiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in TaiwanAnn Oncol200415461862515033670
   PubMed Web of Science ®Google Scholar
• LoYMChanWYNgEKCirculating Epstein-Barr virus DNA in the serum of patients with gastric carcinomaClin Cancer Res2001771856185911448896
   PubMed Web of Science ®Google Scholar
• ChanKCZhangJChanATMolecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patientsCancer Res20036392028203212727814
   PubMed Web of Science ®Google Scholar
• LeungSFChanKCMaBBPlasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinomaAnn Oncol20142561204120824638904
   PubMed Web of Science ®Google Scholar
• LinJCWangWYChenKYQuantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinomaN Engl J Med2004350242461247015190138
   PubMed Web of Science ®Google Scholar
• MusacchioJGCarvalho MdaGMoraisJCDetection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin’s diseaseSao Paulo Med J2006124315415717119693
   PubMedGoogle Scholar
• KwonJMParkYHKangJHThe effect of Epstein-Barr virus status on clinical outcome in Hodgkin’s lymphomaAnn Hematol200685746346816534596
   PubMed Web of Science ®Google Scholar
• AuWYPangAChoyCChimCSKwongYLQuantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patientsBlood2004104124324915031209
   PubMed Web of Science ®Google Scholar
• KimHSKimKHChangMHWhole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphomaLeuk Lymphoma200950575776319330658
   PubMed Web of Science ®Google Scholar
• StevensSJPronkIMiddeldorpJMToward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimenJ Clin Microbiol20013941211121611283029
   PubMed Web of Science ®Google Scholar
• HakimHGibsonCPanJComparison of various blood compartments and reporting units for the detection and quantification of Epstein-Barr virus in peripheral bloodJ Clin Microbiol20074572151215517494720
   PubMed Web of Science ®Google Scholar
• SpacekMHubacekPMarkovaJPlasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patientsAPMIS20111191101621143522
   PubMed Web of Science ®Google Scholar